Samenvatting
Algemeen is bekend dat het anti-epilepticum fenytoine (Diphantoïne) vergroting van de gingiva tot gevolg kan hebben. Al in 1939 werd hiervan de eerste melding gemaakt.
This is a preview of subscription content, log in via an institution to check access.
Gebruikte literatuur
Dongari-Bagtzoglou A. Research, Science and Therapy Committee, AAP. Drug-associated gingival enlargement. Journal of Periodontology 2004;75:1424-31.
Lindhe J. The Manifestation of systemic disorders. Textbook of Clinical Periodontology 1990;(2nd edition):294-295.
Marshall RI, Bartold PM. A clinical review of drug-induced gingival overgrowths. Australian Dental Journal 1999;44:219-32.
Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. Journal Clinical Periodontology 1996;23:165-75.
Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. Journal Clinical Periodontology 2000;27:217-23.
Trackman PC, Kantarci A. Connective tissue metabolism and gingival overgrowth. Critical Reviews in Oral Biology and Medicine 2004;15:165-75.
Author information
Authors and Affiliations
Additional information
Beide auteurs zijn werkzaam in de Paro Praktijk Utrecht en verbonden aan de afdeling Parodontologie van ACTA, Amsterdam.
Rights and permissions
About this article
Cite this article
van der Weijden, F., Timmerman, M. Gingivavergroting als gevolg van medicatie. TAPR 26, 705–712 (2005). https://doi.org/10.1007/BF03072627
Issue Date:
DOI: https://doi.org/10.1007/BF03072627